MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

Detalles Bibliográficos
Autores principales: Bayley, Rachel, Blakemore, Daniel, García, Paloma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331017/
https://www.ncbi.nlm.nih.gov/pubmed/30680058
http://dx.doi.org/10.18632/oncotarget.26477
_version_ 1783387074141880320
author Bayley, Rachel
Blakemore, Daniel
García, Paloma
author_facet Bayley, Rachel
Blakemore, Daniel
García, Paloma
author_sort Bayley, Rachel
collection PubMed
description
format Online
Article
Text
id pubmed-6331017
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-63310172019-01-24 MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome Bayley, Rachel Blakemore, Daniel García, Paloma Oncotarget Editorial Impact Journals LLC 2018-12-25 /pmc/articles/PMC6331017/ /pubmed/30680058 http://dx.doi.org/10.18632/oncotarget.26477 Text en Copyright: © 2018 Bayley et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Bayley, Rachel
Blakemore, Daniel
García, Paloma
MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
title MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
title_full MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
title_fullStr MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
title_full_unstemmed MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
title_short MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
title_sort mybl2 mrna expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331017/
https://www.ncbi.nlm.nih.gov/pubmed/30680058
http://dx.doi.org/10.18632/oncotarget.26477
work_keys_str_mv AT bayleyrachel mybl2mrnaexpressionasapotentialbiomarkeroftherapeuticresponsetogenotoxictreatmentsinmyelodysplasticsyndrome
AT blakemoredaniel mybl2mrnaexpressionasapotentialbiomarkeroftherapeuticresponsetogenotoxictreatmentsinmyelodysplasticsyndrome
AT garciapaloma mybl2mrnaexpressionasapotentialbiomarkeroftherapeuticresponsetogenotoxictreatmentsinmyelodysplasticsyndrome

Ejemplares similares